Načítá se...
Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step
Infections account for significant morbidity and mortality in liver cirrhosis and most are related to the gut microbiome. Fecal dysbiosis, characterized by an overgrowth of potentially pathogenic bacteria and a decrease in autochthonous non-pathogenic bacteria, becomes prominent with the progression...
Uloženo v:
| Vydáno v: | J Clin Transl Hepatol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
XIA & HE Publishing Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5606971/ https://ncbi.nlm.nih.gov/pubmed/28936406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2017.00008 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|